These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


558 related items for PubMed ID: 23380861

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Incidence and hazards of alloantibodies in renal transplantation.
    Everly MJ.
    Clin Transpl; 2013 Nov; ():313-7. PubMed ID: 25095523
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Impact of persistent preformed and de novo donor-specific antibodies detected at 1 year after kidney transplantation on long-term graft survival in Japan: a retrospective study.
    Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Kanda S, Narita S, Mitobe Y, Habuchi T.
    Clin Exp Nephrol; 2019 Dec; 23(12):1398-1406. PubMed ID: 31493185
    [Abstract] [Full Text] [Related]

  • 32. Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study.
    Everly MJ, Briley KP, Haisch CE, Dieplinger G, Bolin P, Kendrick SA, Morgan C, Maldonado AQ, Rebellato LM.
    Transpl Int; 2017 Jun; 30(6):566-578. PubMed ID: 28211192
    [Abstract] [Full Text] [Related]

  • 33. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 34. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun 01; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 35. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
    Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524
    [Abstract] [Full Text] [Related]

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.
    Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S.
    Clin Transplant; 2012 Feb 20; 26(4):644-56. PubMed ID: 22432638
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.